# Drug Discovery

The Algorithmic Apothecary: Insilico Medicine Nets High-Stakes AI Drug Pact with Eli Lilly

Insilico Medicine has entered a strategic collaboration with Eli Lilly to utilize generative AI for drug discovery, marking a significant milestone in the integration of AI into Big Pharma's R&D pipelines. The partnership validates Insilico's Pharma.AI platform and signals a broader industry shift toward algorithmic molecular design.